Traws Pharma, Inc. Payments of Stock Issuance Costs
Traws Pharma, Inc. (TRAW) reported Payments of Stock Issuance Costs of $730.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-14
- Traws Pharma, Inc. payments of stock issuance costs for the quarter ending 2025-12-31 was $1.94M.
- Traws Pharma, Inc. payments of stock issuance costs for the quarter ending 2025-09-30 was $178.00K.
- Traws Pharma, Inc. payments of stock issuance costs for the quarter ending 2025-06-30 was $164.00K.
- Traws Pharma, Inc. payments of stock issuance costs for the quarter ending 2025-03-31 was $123.00K.
- Traws Pharma, Inc. payments of stock issuance costs for fiscal 2025 was $2.40M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $730.00K 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $2.12M derived: sum of 2 quarters · filed 2026-04-15 | $2.28M derived: sum of 3 quarters · filed 2026-08-14 | $2.40M 10-K · filed 2026-04-15 |
| 2025-09-30 | $178.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $342.00K derived: sum of 2 quarters · filed 2026-08-14 | $465.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $287.00K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $123.00K 10-Q · filed 2026-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |